e-Drug3D

1910

M REVEFENACIN

INN
REVEFENACIN

cas 909800-36-8

CLASS

RESPIRATORY
TREATMENT OF PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)
ANTICHOLINERGIC
MUSCARINIC ANTAGONIST LEADING TO BRONCHODILATION

ROUTE (list)

ATC code

R03BB08

PK parameters

Tmax 0.45 HOUR
PPB 42 PERCENT
t1/2 46 HOUR

Target

TARGET MUSCARINIC RECEPTORS M1 TO M5

Muscarinic acetylcholine receptor M1 UNIPROT P11229 CHRM1

Muscarinic acetylcholine receptor M2 UNIPROT P08172 CHRM2

Download SDF file

4-Piperidinecarboxylic acid, 1-[[4-[[[2-[4-[[([1,1'-biphenyl]-2-ylamino)carbonyl]oxy]-1-piperidinyl]ethyl]methylamino]carbonyl]phenyl]methyl]-

Formula:
C35H42N4O5

Calculated chemical properties:

MW 597.72
NB_atoms 44
XLogP 4.10
PSA 99.848
NB_HD 1
NB_HA 9
fsp3 0.40
Lipinski(0=no;1=yes) 0

FDA
-